This topic contains a solution. Click here to go to the answer

Author Question: For ethical reasons, researchers should compare a new treatment with A) a placebo treatment. B) ... (Read 135 times)

tfester

  • Hero Member
  • *****
  • Posts: 534
For ethical reasons, researchers should compare a new treatment with
 
  A) a placebo treatment.
  B) the currently available treatment.
  C) no treatment.
  D) another experimental treatment.

Question 2

The double-blind control procedure is often used in what type of studies?
 
  A) behavioral studies of weight management
  B) studies on autistic children
  C) drug studies
  D) studies concerned with effects of loss of eyesight



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

shaquita

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

Answer: B

Answer to Question 2

Answer: C



tfester

  • Hero Member
  • *****
  • Posts: 534
Both answers were spot on, thank you once again




 

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Signs and symptoms that may signify an eye tumor include general blurred vision, bulging eye(s), double vision, a sensation of a foreign body in the eye(s), iris defects, limited ability to move the eyelid(s), limited ability to move the eye(s), pain or discomfort in or around the eyes or eyelids, red or pink eyes, white or cloud spots on the eye(s), colored spots on the eyelid(s), swelling around the eyes, swollen eyelid(s), and general vision loss.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

For a complete list of videos, visit our video library